Loading...
XASEMLSS
Market cap67mUSD
Dec 23, Last price  
0.87USD
1D
-5.95%
1Q
-11.22%
Jan 2017
-37.86%
Name

Milestone Scientific Inc

Chart & Performance

D1W1MN
XASE:MLSS chart
P/E
P/S
6.90
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
15.57%
Rev. gr., 5y
0.42%
Revenues
10m
+11.60%
4,751,1866,433,1485,844,1776,390,7136,623,8078,549,0609,749,9688,378,0948,648,24210,011,42010,333,0909,491,56910,482,00511,281,8869,622,0768,374,5015,437,23610,304,7118,805,9069,827,444
Net income
-7m
L-20.41%
-2,996,864-2,754,227-3,152,268-2,938,696-1,187,454-1,530,085-614,508-1,482,100-870,3061,464,930-1,702,024-5,467,522-5,946,507-5,186,793-7,431,645-7,661,564-7,486,699-7,119,021-8,706,131-6,929,104
CFO
-5m
L-11.70%
-4,284,869-3,266,317-1,650,718-1,150,670-442,006402,951-293,777-570,730-49,7181,258,736376,943-2,946,338-5,398,581-1,229,434-1,628,106-1,779,288-6,984,928-4,017,581-6,031,996-5,326,129
Earnings
Mar 27, 2025

Profile

Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.
IPO date
Nov 03, 1995
Employees
20
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
9,827
11.60%
8,806
-14.54%
10,305
89.52%
Cost of revenue
3,736
5,055
4,871
Unusual Expense (Income)
NOPBT
6,091
3,751
5,434
NOPBT Margin
61.98%
42.59%
52.73%
Operating Taxes
(67)
333
Tax Rate
0.01%
NOPAT
6,091
3,817
5,433
Net income
(6,929)
-20.41%
(8,706)
22.29%
(7,119)
-4.91%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,570
4,598
BB yield
-5.12%
-3.24%
Debt
Debt current
227
101
90
Long-term debt
678
893
1,084
Deferred revenue
Other long-term liabilities
Net debt
(5,049)
(7,721)
(13,591)
Cash flow
Cash from operating activities
(5,326)
(6,032)
(4,018)
CAPEX
(5)
(9)
(15)
Cash from investing activities
(2,972)
(9)
(15)
Cash from financing activities
2,561
(9)
4,573
FCF
4,206
3,912
6,917
Balance
Cash
5,954
8,715
14,764
Long term investments
Excess cash
5,463
8,275
14,249
Stockholders' equity
(123,050)
(116,560)
(107,789)
Invested Capital
131,572
127,064
124,591
ROIC
4.71%
3.03%
4.48%
ROCE
71.48%
35.71%
32.34%
EV
Common stock shares outstanding
72,776
70,607
68,830
Price
0.69
43.73%
0.48
-76.70%
2.06
-2.83%
Market cap
50,208
48.14%
33,892
-76.10%
141,790
6.06%
EV
45,373
25,951
128,046
EBITDA
6,242
3,895
5,508
EV/EBITDA
7.27
6.66
23.25
Interest
55
16
Interest/NOPBT
1.46%
0.30%